Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 3, 2017

Issue release date: March 2017

Add all to MyReading List
 
73

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:73-78 (DOI:10.1159/000464146)
Free Access
Editorial
80

HIV-Associated Malignancies

Hübel K.
Oncol Res Treat 2017;40:80-81 (DOI:10.1159/000456716)
Free Access
Review Article
82

HIV-Associated Malignant Lymphoma

Brunnberg U. · Hentrich M. · Hoffmann C. · Wolf T. · Hübel K.
Oncol Res Treat 2017;40:82-87 (DOI:10.1159/000456036)
Free Access
88

HIV-Associated Lung Cancer

Kiderlen T.R. · Siehl J. · Hentrich M.
Oncol Res Treat 2017;40:88-92 (DOI:10.1159/000458442)
94

HIV-Associated Kaposi's Sarcoma

Hoffmann C. · Sabranski M. · Esser S.
Oncol Res Treat 2017;40:94-98 (DOI:10.1159/000455971)
100

HIV-Associated Anal Dysplasia and Anal Carcinoma

Oette M. · Mosthaf F.A. · Sautter-Bihl M.-L. · Esser S.
Oncol Res Treat 2017;40:100-105 (DOI:10.1159/000456715)
106

HIV-Associated Urogenital Malignancies

Hentrich M. · Pfister D.
Oncol Res Treat 2017;40:106-112 (DOI:10.1159/000457130)
 
114

Erratum

Oncol Res Treat 2017;40:114 (DOI:10.1159/000463742)
Free Access
Review Article
115

HIV-Associated Gastrointestinal Cancer

Jensen B.E.-O. · Oette M. · Haes J. · Häussinger D
Oncol Res Treat 2017;40:115-118 (DOI:10.1159/000456714)
120

Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients

Welz T. · Wyen C. · Hensel M.
Oncol Res Treat 2017;40:120-127 (DOI:10.1159/000458443)
Original Article
128

Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma

Deng Y. · Chen Y.
Oncol Res Treat 2017;40:128-132 (DOI:10.1159/000455869)
Novel Insights from Clinical Practice
133

Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases

Hu Q. · Zhao J. · Xu J. · Zhou X. · Shui Y. · Shen L. · Wei Q.
Oncol Res Treat 2017;40:133-137 (DOI:10.1159/000455868)
Letter to the Editor
138

Prophylaxis and Treatment of Cancer-Associated Venous Thromboembolism - Comparison Hematologist/ Oncologists versus Angiologist/Phlebologists

Matzdorff A. · Ledig B. · Stücker M. · Riess H.
Oncol Res Treat 2017;40:138-140 (DOI:10.1159/000456670)
Free Access
 
141

Reports of Oncological Societies

Oncol Res Treat 2017;40:141-148 (DOI:10.1159/000463522)
Free Access
149

PharmaForum

Oncol Res Treat 2017;40:149 (DOI:10.1159/000464150)
Free Access
150

PharmaForum

Oncol Res Treat 2017;40:150-151 (DOI:10.1159/000464151)
Free Access
152

PharmaForum

Oncol Res Treat 2017;40:152-153 (DOI:10.1159/000464152)
Free Access
155

PharmaNews

Oncol Res Treat 2017;40:155 (DOI:10.1159/000464153)
Free Access
156

PharmaNews

Oncol Res Treat 2017;40:156 (DOI:10.1159/000464154)
Free Access
157

PharmaNews

Oncol Res Treat 2017;40:157-160 (DOI:10.1159/000464155)
Free Access
162

Meetings and Conferences

Oncol Res Treat 2017;40:162-163 (DOI:10.1159/000463520)
Free Access